Nuo Therapeutics, Inc. (AURX) Operating margin 2017–2025
Nuo Therapeutics, Inc. (AURX) operating margin by fiscal year — reported operating income divided by reported revenue.
-76.0%FY2025 · since FY2017: -2154.4% → -76.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -76.0% | +104.1 pp |
| FY2024 | -180.0% | +340.6 pp |
| FY2023 | -520.6% | +2437.6 pp |
| FY2022 | -2958.2% | — |
| FY2019 | -663.0% | -553.2 pp |
| FY2018 | -109.8% | +2044.6 pp |
| FY2017 | -2154.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice